Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Souery

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
Journal of Affective Disorders|June 15, 2013
Social adjustment among treatment responder patients with mood disordersAlessandro Serretti, Alberto Chiesa, Daniel Souery, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 15, 2019
Social dysfunction in mood disorders and schizophrenia: Clinical modulators in four independent samplesStefano Porcelli, Siegfried Kasper, Joseph Zohar, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 13, 2020
Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter studyMarkus Dold, Lucie Bartova, Gernot Fugger, et al.
The International Journal of Neuropsychopharmacology|June 4, 2018
Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)Markus Dold, Lucie Bartova, Gernot Fugger, et al.
Journal of Affective Disorders|October 10, 2022
Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patternsVincenzo Oliva, Giuseppe Fanelli, Siegfried Kasper, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 20, 2025
Schizophrenia Genetics Modulates Clinical Depressive FeaturesAlessandro Serretti, Daniel Souery, Siegfried Kasper, et al.
Translational Psychiatry|February 19, 2020
A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotypingChiara Fabbri, Siegfried Kasper, Alexander Kautzky, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 13, 2022
Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic studyMarco Calabrò, Chiara Fabbri, Siegfried Kasper, et al.
International Clinical Psychopharmacology|July 14, 2009
Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patientsAlessandro Serretti, Raffaella Calati, Isabelle Massat, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 6, 2022
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countriesGernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
Journal of Affective Disorders|June 15, 2013
Social adjustment among treatment responder patients with mood disordersAlessandro Serretti, Alberto Chiesa, Daniel Souery, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 15, 2019
Social dysfunction in mood disorders and schizophrenia: Clinical modulators in four independent samplesStefano Porcelli, Siegfried Kasper, Joseph Zohar, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 13, 2020
Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter studyMarkus Dold, Lucie Bartova, Gernot Fugger, et al.
The International Journal of Neuropsychopharmacology|June 4, 2018
Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)Markus Dold, Lucie Bartova, Gernot Fugger, et al.
Journal of Affective Disorders|October 10, 2022
Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patternsVincenzo Oliva, Giuseppe Fanelli, Siegfried Kasper, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 20, 2025
Schizophrenia Genetics Modulates Clinical Depressive FeaturesAlessandro Serretti, Daniel Souery, Siegfried Kasper, et al.
Translational Psychiatry|February 19, 2020
A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotypingChiara Fabbri, Siegfried Kasper, Alexander Kautzky, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 13, 2022
Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic studyMarco Calabrò, Chiara Fabbri, Siegfried Kasper, et al.
International Clinical Psychopharmacology|July 14, 2009
Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patientsAlessandro Serretti, Raffaella Calati, Isabelle Massat, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 6, 2022
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countriesGernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
Pageof 17